31 August 2020

The efficacy and safety of about half of all drugs prescribed to children has not been adequately researched. Because growth and development change the way a child's body deals with drugs, it runs an increased risk of receiving ineffective or unsafe drugs. Although many children need medication, the optimal dosage is often not known.

The Department of Pharmacology and Toxicology of the Radboudumc has started further research into more effective and safer drug doses for children, with the help of a grant from the Bill & Melinda Gates Foundation. Under the leadership of Saskia de Wildt and together with the Kinderformularium, predictive models or 'virtual children' will be used to determine the optimal dosage for children of different ages.

To ensure that children throughout Europe receive these optimized doses, the doses will be made available to doctors and pharmacists via the Kinderformularium and internationally affiliated websites. Doctors and pharmacists will be trained to use these 'virtual' children and to include dosage recommendations in the guidelines for the treatment of children. 

Related news items


Young Radboudumc researchers receive grant to engage in bio-medical and health research that is off the beaten path

16 September 2021

The ZonMw Off Road program is once again giving young scientists the opportunity to conduct innovative research in medical and/or health care. This research is off the beaten track and aims to bring about new insights and unexpected breakthroughs for healthcare and healthcare innovation.

read more

Depressive symptoms during pregnancy affect baby

16 September 2021

Study in Obstetrics & Gynecology shows associations between depression and adverse birth outcomes

read more

ENABLECARES launches a course on entrepreneurship for PhD candidates and postdocs

15 September 2021

Are you thinking about what to do after your PhD? Want to know more about entrepreneurship? This course gives you insight in many aspects of entrepreneurship and research in industry.

read more

Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias

15 September 2021

Lia Goltstein and colleagues published a study about effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.

read more

Two million euros for improved treatment and outcomes of COVID-19 in the elderly

10 September 2021

ZonMw awarded a grant of nearly two million euros to a large group of researchers to improve the outcomes of elderly people with COVID-19. The study, in which the Radboudumc also participates, provides insight into the course and treatment of COVID-19 in the elderly.

read more

RIHS PhD retreat Registration open

9 September 2021

Mark your agendas: the next RIHS PhD retreat will take place on 25 and 26 November 2021! This year's theme is ‘Mastering your career: life after your dissertation and how to take control’. With keynote speakers: Marcel Levi and Louise Gunning-Schepers.

read more